Home

About Us

Site Map

Search for

Online Learning & Teaching

Webcasts

ESC Slide Resource

World Congress of Cardiology - ESC Congress 2006

ESC Congress 2005 Stockholm

ESC Congress 2004 Munich

ESC Congress 2003 Vienna

Management of CVD Risk in the Perimenopausal Woman 2006

EACPR Leuven Spring Meeting 2005

Heart Failure 2005

ESC Policy Conference on CVD in Women

Education in Heart

Educational Programme Resources

Scientific and Knowledge Search

Clinical Case Portal
Echocardiography

Heart Failure Scientific Reports

CME Calendar

Where do we stand adter the latest WHI data?

Presentation title: Where do we stand adter the latest WHI data?

Author(s): Palacios S.

Date: 12 May 2006

[Download complete file]

Click a thumbnail below to view an individual slide:
		I) HT Market World
HT Market Development World (2001 - 2005)	HT Market: Utilisation Rates and Number of HT Womenper Region (2001 – 2005)	II) HT Market USA
HT Market Development in Euro USA (2001 - 2005)	III) HT Market Europe	HT Market Development Region Europe (2001 - 2005)
IV) HT Market Latin America/ Canada	HT Market Development Region Latin America/ Canada (2001 - 2005)	Ratio 2002 contra otros THS (unidades)
Patrón de Prescripción de TH y de Antidepresivos: Una Relación Recíproca	Reasons Women Gave for Initiating or Continuing HT	Reasons Women Gave for Initiating or Continuing HT
Post-WHI Survey	Post-WHI Telephone Interviews of Kaiser Permanente Patients	Post-WHI Telephone Interviews of Kaiser Permanente Patients (continued)
HT Use After the WHI	Hormone Therapy	WHI Coronary Heart Disease Results
WHI E+P Trial: Time Since Menopause May Be Better Than Age at Predicting CHD Risk with HT	WHI E+P Trial: Timing of HT Initiation May Affect Risk of CHD Events	WHI E+P Trial: Effect of Body Mass Index, Statin Use, and Aspirin Use
WHI E+P Trial: Effect of Baseline Lipid Levels on CHD Risk	WHI E-Alone Trial: Effect of Unopposed CEE on Risk of CHD by Age	WHI: Final Results Effect of CEE/MPA on Risk of CHD
WHI: Final Results	WHI Results: Effect of CEE Alone on Risk of CHD	WHI E+P Study: Incidence of Diabetes
WHI E+P Trial: Changes in Glucose and Insulin*	WHI E+P Trial: Change in Insulin Resistance*	All-Cause Mortality Was Not Affected by HRT in WHI or HERS
WHI Venous Thromboembolism Results	WHI HT Trials: Increased Risk of Venous Thromboembolism	WHI E+P Trial: Age-Specific Risk of Venous Thrombosis With E+P
WHI ET and HT Outcomes	CEE AND CORONARY HEART DISEASE: THE WHI	THE RULE OF TIME SINCE MENOPAUSE AND AGE AT HORMONE INITIATION
	PROGESTINS AFFECT C-REACTIVE PROTEIN: PEPT STUDY
	DISCREPANCY BETWEEN OBSERVATIONAL STUDIES AND THE WHI	CORONARY EVENTS AND HT
		KEEPSTHE KRONOS EARLY ESTROGEN PREVENTION STUDY

	WHI	WHI Results: Overall Relative Risk
WHI Results: Overall Attributable Risk	WHI: Results With CEE/MPA and CEE Alone	WHI: Results With CEE/MPA and CEE Alone
Interpretation of the WHI Data	2004 ACOG Executive Summary on HT	2003 NAMS Position Statement on HT
Indications for Extended Use of HT	Summary of NIH Recommendations

There are no polls available right now.

Site Map | Contact Us | Terms & Conditions | Privacy